Differential effects of glucose‐dependent insulinotropic polypeptide receptor/glucagon‐like peptide‐1 receptor heteromerization on cell signaling when expressed in <scp>HEK</scp> ‐293 cells-Reference-Cited by-同舟云学术

Differential effects of glucose‐dependent insulinotropic polypeptide receptor/glucagon‐like peptide‐1 receptor heteromerization on cell signaling when expressed in HEK ‐293 cells

Published:2022-09-30 Issue:5 Volume:10 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacology Res & Perspec

Author:

Al‐Zaid Bashaier¹,Chacko Siby¹,Ezeamuzie Charles Ifeamalume¹,Bünemann Moritz²,Krasel Cornelius²,Karimian Tina³,Lanzerstorfer Peter³,Al‐Sabah Suleiman¹^ORCID

Affiliation:

1. Department of Pharmacology and Toxicology, Faculty of Medicine Kuwait University Kuwait City Kuwait

2. School of Pharmacy, Institute for Pharmacology and Toxicology The Philipps University of Marburg Marburg Germany

3. University of Applied Sciences Upper Austria, School of Engineering Wels Austria

Funder

College of Graduate Studies, Kuwait University

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.1013

Reference55 articles.

1. Incretin Effects of Increasing Glucose Loads in Man Calculated from Venous Insulin and C-Peptide Responses*

2. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

3. Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

4. GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

5. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GIP-derived GIP receptor antagonists – a review of their role in GIP receptor pharmacology;Peptides;2024-07

2. Pharmacological Advances in Incretin-Based Polyagonism: What We Know and What We Don’t;Physiology;2024-05-01

3. Insulin receptor-inspired soluble insulin binder;European Journal of Cell Biology;2023-06

4. G Protein-Coupled Receptors and the Rise of Type 2 Diabetes in Children;Biomedicines;2023-05-29

5. Variation in responses to incretin therapy: Modifiable and non-modifiable factors;Frontiers in Molecular Biosciences;2023-04-07